Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Stomach Neoplasms 3Gastroesophageal Reflux 2Barrett Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Compression 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Non-Erosive Reflux Disease 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Hemorrhage 1Helicobacter Infections 1Head and Neck Neoplasms 1Fatigue 1Familial primary gastric lymphoma 1Delayed Bleeding 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Atrophy 1

Interventions

Vitamin D 1Therapeutics 1Proton Pump Inhibitors 1Probiotics 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Helicobacter Infections × Proton Pump Inhibitors × Clear all
NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡